Tonix Pharmaceuticals Holding Corp (TNXP)
0.1394
+0.01
(+10.63%)
USD |
NASDAQ |
Oct 04, 16:00
0.1392
0.00 (0.00%)
Pre-Market: 20:00
Tonix Pharmaceuticals Shareholders Equity (Annual): 105.52M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 105.52M |
| December 31, 2022 | 207.18M |
| December 31, 2021 | 218.72M |
| December 31, 2020 | 87.65M |
| December 31, 2019 | 9.417M |
| December 31, 2018 | 23.66M |
| December 31, 2017 | 24.62M |
| December 31, 2016 | 25.36M |
| Date | Value |
|---|---|
| December 31, 2015 | 40.26M |
| December 31, 2014 | 36.09M |
| December 31, 2013 | 6.512M |
| December 31, 2012 | 0.959M |
| December 31, 2011 | -2.454M |
| December 31, 2010 | -0.1755M |
| December 31, 2009 | 0.012M |
| December 31, 2008 | 0.0429M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
9.417M
Minimum
2019
218.72M
Maximum
2021
125.70M
Average
105.52M
Median
2023
Shareholders Equity (Annual) Benchmarks
| Emergent BioSolutions Inc | 649.30M |
| Abbott Laboratories | 38.60B |
| SIGA Technologies Inc | 196.86M |
| Chimerix Inc | 193.03M |
| Co-Diagnostics Inc | 86.01M |